Cargando…
Entwicklungsansätze für Impfstoffe gegen Hepatitis-C-Virus-Infektionen
The incidence of hepatitis C virus (HCV) infections remains high even more than 10 years after approval of the first direct-acting antivirals for treatment of hepatitis C. In some countries, more people are newly infected with the virus than patients cured by antiviral therapy. The development of a ...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749110/ https://www.ncbi.nlm.nih.gov/pubmed/35015104 http://dx.doi.org/10.1007/s00103-021-03477-9 |